José Luís García-Giménez
José Luís García-Giménez is a Ph.D. Researcher of the Center for Biomedical Network Research on Rare Diseases (CIBERER) of the National Institute of Health ISCIII (Spain). He received his degree in chemical science in 2002 and his degree in biochemistry in 2004. Afterwards, he received his Ph.D. degree in University of Valencia where he was in Hake's lab in Adolf Butenandt Institute, LMU University, Munich (Germany), one of the most important epigenetic laboratories in Europe. Dr. García-Giménez has published more than 35 manuscripts and 10 book chapters regarding oxidative stress, redox signalling, rare diseases, epigenetics, and the importance of epigenetic biomarkers in clinical diagnostics. Dr. García-Giménez has participated in more than 20 research projects as collaborator and principal investigator. Furthermore, he patented a method to detect carbonylated histones and their variants. He is the Editor-in-Chief of Elsevier's Book Epigenetic Biomarkers and Diagnostics. The research field of Dr. García-Giménez comprises the study of the physiopathology of Rare Diseases, the implications of the oxidative stress, and the regulation of the epigenetics in ageing and diseases.
Biography Updated on 2 April 2015